Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Selectis Health (GBCS) over the last 10 years, with Q3 2025 value amounting to $29.3 million.

  • Selectis Health's Non-Current Assets fell 357.84% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year decrease of 1024.51%. This contributed to the annual value of $29.9 million for FY2024, which is 1623.48% down from last year.
  • Latest data reveals that Selectis Health reported Non-Current Assets of $29.3 million as of Q3 2025, which was down 357.84% from $29.6 million recorded in Q2 2025.
  • Selectis Health's Non-Current Assets' 5-year high stood at $39.1 million during Q1 2021, with a 5-year trough of $29.3 million in Q3 2025.
  • For the 5-year period, Selectis Health's Non-Current Assets averaged around $35.2 million, with its median value being $36.8 million (2023).
  • Per our database at Business Quant, Selectis Health's Non-Current Assets plummeted by 122.95% in 2022 and then tumbled by 1654.74% in 2024.
  • Quarter analysis of 5 years shows Selectis Health's Non-Current Assets stood at $39.0 million in 2021, then dropped by 3.67% to $37.5 million in 2022, then fell by 4.83% to $35.7 million in 2023, then fell by 16.23% to $29.9 million in 2024, then dropped by 2.03% to $29.3 million in 2025.
  • Its Non-Current Assets stands at $29.3 million for Q3 2025, versus $29.6 million for Q2 2025 and $29.8 million for Q1 2025.